# US 2012/0255041 A1 · Transgenic non-human animal and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0255041 A1
- Document ID: US20120255041A1
- Status: Published application
- Kind: A1
- Application number: 13/516,077
- Filed: 2010-12-17
- Published: 2012-10-04
- Earliest claimed: 2009-12-21
- Assignees: Sanofi
- Inventors: Holly Dressler; Kyriakos D. Economides; Zhen Pang; Harry Gregory Polites
- Web page: https://patentgrep.com/patent/US20120255041A1

## CPC

- G01N 33/74: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 15/8509: {for producing genetically modified animals, e.g. transgenic}
- A01K 2217/052: inducing gain of function
- A01K 2217/203: Animal model comprising inducible/conditional expression system, e.g. hormones, tet
- A01K 2227/105: Murine
- A01K 2267/0393: Animal model comprising a reporter system for screening tests
- C12N 2800/107: for mammalian
- C12N 2830/002: inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12N 2830/15: chimeric enhancer/promoter combination
- C12N 2830/40: being an insulator
- C12N 2830/46: elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
- C12N 2830/50: regulating RNA stability, not being an intron, e.g. poly A signal
- C12N 2830/60: from viruses
- C12N 2830/85: mammalian
- G01N 2333/726: G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates generally to transgene constructs, transgenic non-human animals comprising transgene constructs, methods of making and methods of using the transgenic non-human animals comprising transgene constructs. An embodiment of the invention relates to methods of assaying the activation of GPCR ligands non-invasively in whole animals, tissue slices, or in native cells using a transgenic model containing a bioluminescent transgene reporter system that is responsive to pathway modulation following ligand binding of GPCR receptors.

## Claims

### Claim 1

A transgenic non-human animal having a genome comprising a transgene comprising a first insulator element, a response element, a promoter, a bioluminescent reporter, a functional element and a second insular element.

### Claim 2 (depends on 1)

The transgenic non-human animal of claim 1, wherein the first insulator element is selected from the group consisting of matrix attachment regions (MAR), DNase I-hypersensitive site (HS4) and inverted terminal repeats (ITR).

### Claim 3 (depends on 1)

The transgenic non-human animal of claim 1, wherein the second insulator element is selected from the group consisting of matrix attachment element (MAR), HS4 and ITR.

### Claim 4 (depends on 1)

The transgenic non-human animal of claim 1, wherein the first insulator element is the same as the second insulator element.

### Claim 5 (depends on 1)

The transgenic non-human animal of claim 1, wherein the response element is selected from the group consisting of cAMP response element (CRE), activator protein 1 (ASP1), glucocorticoid response element (GRE), heat shock response element (HSE), serum response element (SRE), thyroid response element (TRE) and estrogen response element (ERE).

### Claim 6 (depends on 5)

The transgenic non-human animal of claim 5, wherein the response element is repeated in tandem two to twenty-four times.

### Claim 7 (depends on 6)

The transgenic non-human animal of claim 6, wherein the response element is repeated in tandem six times.

### Claim 8 (depends on 7)

The transgenic non-human animal of claim 7, wherein the response element is CRE.

### Claim 9 (depends on 1)

The transgenic non-human animal of claim 1, wherein the promoter is herpes simplex virus thymidine kinase minimal (HSV TK min).

### Claim 10 (depends on 1)

The transgenic non-human animal of claim 1, wherein the bioluminescent reporter is selected from the group consisting of luciferase, chloramphenicol acetyltransferase (CAT), beta-galactosidase, secreted alkaline phosphatase (SEAP), human growth hormone (HGH) and green fluorescent protein (GFP).

### Claim 11 (depends on 1)

The transgenic non-human animal of claim 1, wherein the functional element is human growth hormone (hGH) gene.

### Claim 12 (depends on 1)

The transgenic non-human animal of claim 1, wherein the transgene comprises SEQ ID NO: 18.

### Claim 13 (depends on 11)

The transgenic non-human animal of claim 11, wherein the transgene comprises SEQ ID NO: 19.

### Claim 14 (depends on 1)

A cell isolated from the transgenic non-human animal of claim 1.

### Claim 15 (depends on 1)

A tissue slice isolated from the transgenic non-human animal of claim 1.

### Claim 16 (depends on 1)

A method of identifying a G protein-coupled receptor (GPCR) ligand, the method comprising:
(a) measuring an amount of bioluminescence in the transgenic non-human animal of claim 1;
(b) administering a test agent to the transgenic non-human animal;
(c) measuring an amount of bioluminescence of the transgenic non-human animal at one or more time points following administration of the test agent; and
(d) comparing the amount of bioluminescence measured in (a) to the amount of bioluminescence measured in (c)
wherein a difference in the amount of bioluminescence in (a) compared to (c) identifies the test agent as a GPCR ligand.

### Claim 17 (depends on 1)

A method of identifying a G protein-coupled receptor (GPCR) ligand, the method comprising:
(a) preparing a tissue slice from the transgenic non-human animal of claim 1;
(b) measuring an amount of bioluminescence in the tissue slice;
(c) administering a test agent to the tissue slice;
(d) measuring an amount of bioluminescence of the tissue slice at one or more time points following administration of the test agent; and
(e) comparing the amount of bioluminescence measured in (b) to the amount of bioluminescence measured in (d)
wherein a difference in the amount of bioluminescence in (b) compared to (d) identifies the test agent as a GPCR ligand.

### Claim 18 (depends on 1)

A method of identifying a G protein-coupled receptor (GPCR) ligand, the method comprising:
(a) preparing a cell isolated from the transgenic non-human animal of claim 1;
(b) measuring an amount of bioluminescence in the cell;
(c) administering a test agent to the cell;
(d) measuring an amount of bioluminescence in the cell at one or more time points following administration of the test agent; and
(e) comparing the amount of bioluminescence measured in (b) to the amount of bioluminescence measured in (d)
wherein a difference in the amount of bioluminescence in (b) compared to (d) identifies the test agent as a GPCR ligand.

### Claim 19

A method of monitoring GPCR function in a non-human animal, the method comprising:
(a) transgenically modifying a non-human animal to express a transgene comprising a first insulator element, a response element, a promoter, a bioluminescent reporter, a functional element and a second insular element;
(b) monitoring bioluminescence from the non-human animal; and
(c) correlating said bioluminescence to GPCR function.

### Claim 20

A method of making a non-human transgenic animal for use in monitoring GPCR function, the method comprising:
(a) transgenically modifying a non-human animal to express a transgene comprising a first insulator element, a response element, a promoter, a bioluminescent reporter, a functional element and a second insular element;
(b) measuring an amount of bioluminescence in the transgenic non-human animal of (a);
(c) administering a GPCR ligand to the transgenic non-human animal;
(d) measuring an amount of bioluminescence of the transgenic non-human animal at one or more time points following administration of the GPCR ligand; and
(e) comparing the amount of bioluminescence measured in (b) to the amount of bioluminescence measured in (d)
wherein a difference in the amount of bioluminescence in (b) compared to (d) identifies the non-human transgenic animal for use in monitoring GPCR function.
